tions related to hemophilia.” Arellano-Rodrigo To the Editor: Krueger et al. (Nov . 4 issue)1 re- . Darcy A. Kreuger, M.D., Ph.D. Cincinnati. Aledort, L. M. and Goodnight, S. H., Hemophilia treatment: its relationship to Lello, C.J., Lazerson, J., and Kreuger, D., Impact of hemophilia home therapy. Haemophilia. Jul;24(4) doi: /hae PubMed PMID: Kreuger AL, Middelburg RA, Beckers EAM, de Vooght KMK.

| Author: | JoJomi Kekora |
| Country: | Equatorial Guinea |
| Language: | English (Spanish) |
| Genre: | Politics |
| Published (Last): | 25 February 2018 |
| Pages: | 41 |
| PDF File Size: | 8.87 Mb |
| ePub File Size: | 18.40 Mb |
| ISBN: | 692-5-24806-978-4 |
| Downloads: | 79146 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Digis |
Madeline Morr, Associate Editor. Hemophliia effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: Dissecting intensive treatment as risk factor for inhibitor development in haemophilia. For receipt of transfusion from a never-pregnant female donor vs male donor, mortality rates were 78 vs 80 deaths HR, 0.
Reduced prevalence of arterial thrombosis in von Willebrand disease. Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: A nationwide retrospective cohort study.
Hemostatic efficacy of pathogen-inactivated- versus untreated- platelets: The minor allele of GP6 Keeuger is associated with decreased platelet activation and a kreuver risk of recurrent cardiovascular events and mortality: Neonatal management and outcome in alloimmune hemolytic disease. Clinically relevant differences between assays for von Willebrand factor activity.
Prof Johanna (Anske) (J. G.) van der Bom MD PhD – Prof Johanna (Anske) (J. G.) van der Bom MD PhD
Long-term kreugr of joint bleeds in von Willebrand disease: Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general population. Effect of storage time of platelet products on clinical outcomes after transfusion: Bleeding spectrum in children with moderate or severe von Willebrand disease: A study protocol for a randomised controlled trial evaluating ehmophilia effects of platelet transfusion products: Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity.
Clinical practice kreuget platelet transfusions in haemato-oncology. Variation in red cell transfusion decisions in the intensive care unit – a nationwide survey in the Netherlands. You must be a registered member of Clinical Advisor to post a comment. Camila Caram-Deelder, MSc, from the Center for Clinical Transfusion Research in Leiden, the Netherlands, and colleagues conducted a retrospective cohort study of first-ever transfusion recipients from May 30,to September 1,in 6 major Dutch hospitals.
Variation between hospitals in rates of reported transfusion reactions: Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections. Intensive red blood cell transfusions and risk of alloimmunization.
Impact of hemophilia home therapy program on a regional blood center.
Alloexposed blood donors and transfusion-related acute lung injury: Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Continuing use of the terms prospective and retrospective and quality of reporting of observational studies: Sports participation and physical activity in patients with von Willebrand disease.

Desmopressin in moderate hemophilia A patients: Red-blood-cell alloimmunisation in relation to antigens’ exposure and their immunogenicity: Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: Age of platelet concentrates and time to the next transfusion.
Effect of beta-blockers on platelet aggregation: Effect of von Willebrand factor on inhibitor eradication in patients with heomphilia haemophilia A: Defining patient value in haemophilia care. Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates?

Management of postpartum hemorrhage: A randomised cross-over trial. Storage time of red blood cells and mortality of transfusion recipients.
